AWMS
CALA

Advocacy Wealth Management Services’s Calithera Biosciences, Inc CALA Stock Holding History

Advocacy Wealth Management Services’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10
Closed -$1K – 180
2018
Q4 		$1K Hold
10
– – ﹤0.01% 161
2018
Q3 		$1K Hold
10
– – ﹤0.01% 171
2018
Q2 		$1K Hold
10
– – ﹤0.01% 171
2018
Q1 		$1K Hold
10
– – ﹤0.01% 202
2017
Q4 		$2K Hold
10
– – ﹤0.01% 208
2017
Q3 		$3K Hold
10
– – ﹤0.01% 253
2017
Q2 		$3K Hold
10
– – ﹤0.01% 256
2017
Q1 		$2K Buy
+10
New +$1.73K ﹤0.01% 292

Other funds holding CALA

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advocacy Wealth Management Services's CALA Position: Q1 2019 in Review

Advocacy Wealth Management Services sold out of Calithera Biosciences, Inc (CALA) in Q1 2019, closing a stake of 10 shares — an estimated $1K sold.

Advocacy Wealth Management Services first reported a position in CALA in Q1 2017 and held it in 8 quarters. The position peaked at $3K in Q3 2017. 71 funds tracked by Wall St. Rank hold CALA as of Q1 2019.

  • Advocacy Wealth Management Services reported no remaining Calithera Biosciences, Inc position as of Q1 2019 after selling out during the quarter.
  • Advocacy Wealth Management Services sold 10 Calithera Biosciences, Inc shares in Q1 2019, an estimated $1K.
  • Advocacy Wealth Management Services first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 8 quarters.
  • Advocacy Wealth Management Services's Calithera Biosciences, Inc position peaked at $3K in Q3 2017.
  • 71 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2019.

Based on Advocacy Wealth Management Services's 13F filing for Q1 2019, filed 2 Apr 2019.